Evdokia Arkoumani
About
In The Last Decade
Evdokia Arkoumani
20 papers receiving 468 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 189
- Oncology 173
- Cancer Research 129
- Pulmonary and Respiratory Medicine 122
- Pathology and Forensic Medicine 91
Countries citing papers authored by Evdokia Arkoumani
This map shows the geographic impact of Evdokia Arkoumani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evdokia Arkoumani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evdokia Arkoumani more than expected).
Fields of papers citing papers by Evdokia Arkoumani
This network shows the impact of papers produced by Evdokia Arkoumani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evdokia Arkoumani. The network helps show where Evdokia Arkoumani may publish in the future.
Co-authorship network of co-authors of Evdokia Arkoumani
This figure shows the co-authorship network connecting the top 25 collaborators of Evdokia Arkoumani. A scholar is included among the top collaborators of Evdokia Arkoumani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evdokia Arkoumani. Evdokia Arkoumani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Primary squamous cell carcinoma of the ovary. Review of the literature. | 12 |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 10 | |
| 6 | Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report. | 8 |
| 7 | 13 | |
| 8 | 49 | |
| 9 | Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma. | 5 |
| 10 | 54 | |
| 11 | 20 | |
| 12 | Expression of mismatch repair proteins in invasive and in situ carcinoma of the breast. | 3 |
| 13 | 13 | |
| 14 | 63 | |
| 15 | Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. | 54 |
| 16 | 46 | |
| 17 | 33 | |
| 18 | 51 | |
| 19 | The usefulness of p63 as a marker of breast myoepithelial cells. | 34 |
| 20 | Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.